By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply.
Turning Point Therapeutics designs and develops novel small molecules, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. Further, it has also created a new generation of therapies that are different from conventional kinase inhibitors.